Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00000288
DRKS00000288
Recruiting
Not Applicable

Investigation of platelet function and formation of platelet-leukocyte aggregates during initial antiretroviral therapy of HIV-infected adults over 48 weeks - HIV-PLAII

HIVCENTERMedizinische Klinik IIKlinikum der J. W. Goethe-Universität0 sites50 target enrollmentFebruary 17, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsB24Unspecified human immunodeficiency virus [HIV] disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
B24
Sponsor
HIVCENTERMedizinische Klinik IIKlinikum der J. W. Goethe-Universität
Enrollment
50
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 17, 2010
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
HIVCENTERMedizinische Klinik IIKlinikum der J. W. Goethe-Universität

Eligibility Criteria

Inclusion Criteria

  • •patients with assured HIV\-1\-infection
  • •\- therapy\-naive patients; patients that took ART (antiretroviral therapy) medication for not longer than two weeks in context with a clinical study more than 3 months before inclusion into this observational study, should be regarded as therapy\-naive, too.
  • •\- treated ambulantly or in hospital
  • •\- written informed consent

Exclusion Criteria

  • •\- neurological diseases, influencing the patients? cognition
  • •\- manifest psychoses and/or severe psychiatric diseases that seem to interfere with the patients? comprehension for the sense, risk and needs of this study
  • •\- apparent limitations of compliance due to addiction to, drugs or pharmaceuticals
  • •\- haemoglobin \< 10g/dl in men or \< 8g/dl in women, respectively
  • •\- thrombocytopenia with \< 50\.000 platelets/µl blood
  • •\- known and untreated blood coagulation disorders
  • •\- diabetes
  • •\- untreated hypertension with a systolic/diastolic blood pressure of \> 140/90
  • •\- cholesterol plasma levels of \> 250mg/dL
  • •\- body mass index (BMI) \> 35

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Platelet reactivity and formation of platelet-monocyte complexes in patients with chronic obstructive pulmonary disease (COPD)COPD chronic obstructive pulmonary disease100110821000643610003216
NL-OMON42526ongziekten50
Completed
Phase 4
ASsesment of Platelet function and Inhibition in patients Recovering from severe INfectionAcute myocardial infarctionHeart attack10011082
NL-OMON50157Vrije Universiteit Medisch Centrum97
Active, not recruiting
Phase 1
Evaluation of platelet activity in patients recovering from a severe infectioHyperaggregability of thrombocytes triggered by severe infection (i.e. pneumonia or invasive urinary tract infection or a cutaneous infection).Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2016-004303-32-NLVU university medical center62
Recruiting
Not Applicable
A prospective study of platelet derived microparticles in pediatric patients with coagulopathy afer hematopoietic stem cell transplantation.Pediatirc hematopoietic stem cell tranaplantaion
JPRN-UMIN000026864niversity of the Ryukyus Faculty of Medicine30
Completed
Not Applicable
Platelet Responsiveness and Outcome from Platelet Transfusion (PROmPT)ational Cancer Research Network, BloodCancer
ISRCTN56366401HS Blood and Transplant [NHSBT] (UK)130